i) Rights Issue by Material Unlisted Subsidiary Companies ii) Investment in Equity shares of wholly owned Material Subsidiaries of the Company

FISCHER MEDICAL VENTURES LIMITED (Formerly known as Fischer Chemic Limited) Registered Office Address: Survey No. 480/2 AP Medtech Zone, Nadupura Village, Pedagantyadu Mandal, Visakhapatnam, 530032 CIN: L86900AP1993PLC118162 Email: cs@fischermv.com | Website: www.fischermv.com | Contact 9080966548 September 24, 2026 BSE Limited National Stock Exchange of India Ltd. Corporate Relationship Department Exchange Plaza, 5tll floor 25th Floor, P J Towers Plot No. C/ 1, G Block, Dalal Street, Fort, Bandra-Kurla Complex Bandra (E), Mumbai – 400 001. Mumbai - 400 051. BSE Scrip Code: 524743 NSE Symbol: FISCHER Dear Sir/ Madam, Sub: Outcome of Board Meeting held on 24th September, 2026 Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors have inter-alia approved and taken on record the following at its meeting held today (24/09/2026): 1. Rights Issue by Material Unlisted Subsidiary Companies (i) Time Medical International Ventures (India) Private Limited, a Wholly Owned Subsidiary of the Company and a material subsidiary under Regulation 24(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, has issued 15,603 equity shares at an issue price of ₹ 7,370.25 per equity share by way of a rights issue. (ii) Flynncare Health Innovations Private Limited, the Wholly Owned Subsidiary of the Company and also a material subsidiary under Regulation 24(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, has issued 1,507 equity shares at an issue price of ₹82,943.48 per equity share by way of a rights issue. (iii) FMV Global Innovation Pte. Ltd., the Wholly Owned Subsidiary of the Company and also a material subsidiary under Regulation 24(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, has issued 53 equity shares at an issue price of ₹48,83,552.64 per equity share by way of a rights issue. 2. Investment in Equity shares of wholly owned Material Subsidiaries of the Company The Board of Directors considered and approved the proposal for investment by the Company in the rights issues proposed to be undertaken by its wholly owned subsidiary companies, namely, Corporate Office: Level 8, Prestige Palladium Bayan, No. 129-140 Greams Road, Chennai, Tamil Nadu, 600006 FISCHER MEDICAL VENTURES LIMITED (Formerly known as Fischer Chemic Limited) Registered Office Address: Survey No. 480/2 AP Medtech Zone, Nadupura Village, Pedagantyadu Mandal, Visakhapatnam, 530032 CIN: L86900AP1993PLC118162 Email: cs@fischermv.com | Website: www.fischermv.com | Contact 9080966548 (a) Time Medical International Ventures (India) Private Limited, (b) FlynnCare Health Innovations Private Limited and (c) FMV Global Innovation Pte. Ltd., by subscribing to the equity shares offered by the respective entities pursuant to their respective rights issues, subject to the terms and conditions and applicable laws. The details as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015 are given in Annexure. The Board Meeting commenced at 02:15 PM (IST) and concluded at 4:10 PM (IST) Please take on record. Thanking You, Yours Truly, FoFor FISCHER MEDICAL VENTURES LIMITED BALAJI GANDLA COMPANY SECRETARY AND COMPLIANCE OFFICER Corporate Office: Level 8, Prestige Palladium Bayan, No. 129-140 Greams Road, Chennai, Tamil Nadu, 600006 FISCHER MEDICAL VENTURES LIMITED (Formerly known as Fischer Chemic Limited) Registered Office Address: Survey No. 480/2 AP Medtech Zone, Nadupura Village, Pedagantyadu Mandal, Visakhapatnam, 530032 CIN: L86900AP1993PLC118162 Email: cs@fischermv.com | Website: www.fischermv.com | Contact 9080966548 ANNEXURE Sr. Particulars Details 1 Name of the target entity, details Time Medical International Ventures (India) Private Limited in brief such as size, turnover etc. Turnover: 5,500.50 lakhs for FY 2025-26 2 Whether the acquisition would fall Time Medical International Ventures (India) Private Limited is within related party the wholly owned material subsidiary of the Company. transaction(s)and whether the promoter/ promoter group/ group Accordingly, Time Medical International Ventures (India) Private companies have any interest in the Limited is a related party. entity being acquired? The transaction is done at Arm’s Length and supported by a If yes, nature of interest and details valuation report issued by a Registered Valuer. thereof and whether the same is done at “arm’s length”. 3 Industry to which the entity Healthcare acquired belongs 4 Objects and effects of acquisition Not Applicable. (including but not limited to, disclosure of reasons for acquisition of target entity, if its business is outside the main line of business of the listed entity) 5 Brief details of any governmental or Not Applicable. regulatory approvals required for the acquisition. 6 Indicative time period for Not Applicable. completion of the acquisition. 7 Nature of consideration - whether Cash cash consideration or share swap and details of the same. 8 Cost of acquisition or the price INR 11,50,00,000 at which the shares are acquired. 9 Percentage of shareholding/ control 100% acquired and/ or number of shares acquired. Corporate Office: Level 8, Prestige Palladium Bayan, No. 129-140 Greams Road, Chennai, Tamil Nadu, 600006 FISCHER MEDICAL VENTURES LIMITED (Formerly known as Fischer Chemic Limited) Registered Office Address: Survey No. 480/2 AP Medtech Zone, Nadupura Village, Pedagantyadu Mandal, Visakhapatnam, 530032 CIN: L86900AP1993PLC118162 Email: cs@fischermv.com | Website: www.fischermv.com | Contact 9080966548 10 Brief background about the entity Time Medical International Ventures (India) Private Limited acquired in terms of products/line of (“TMIV”) is engaged in the medical diagnostic imaging industry, business acquired, date of with a focus on developing and providing advanced and affordable incorporation, history of last 3 years medical imaging solutions. The company has capabilities in the turnover, country in which the development and manufacture of medical imaging systems, acquired entity has presence and any including Magnetic Resonance Imaging (MRI) systems, and operates other significant information (in a manufacturing facility at the Andhra Pradesh MedTech Zone (AMTZ), Visakhapatnam. TMIV has also developed cost-effective brief). service solutions for the medical imaging sector. Date and Country of Incorporation: 10-01-2019, India Turnover for FY 2025-26: 5,500.05 lakhs Turnover for FY 2024-25: 8,273.58 lakhs Turnover for FY 2023-24: 2,162.34 lakhs Sr. Particulars Details 1 Name of the target entity, details Flynncare Health Innovations Private Limited in brief such as size, turnover etc. Turnover: 8,629.26 lakhs 2 Whether the acquisition would fall Flynncare Health Innovations Private Limited is the wholly within related party owned material subsidiary of the Company. transaction(s)and whether the promoter/ promoter group/ group Accordingly, Flynncare Health Innovations Private Limited is a companies have any interest in the related party. entity being acquired? The transaction is done at Arm’s Length and supported by a If yes, nature of interest and details valuation report issued by a Registered Valuer. thereof and whether the same is done at “arm’s length”. 3 Industry to which the entity Healthcare acquired belongs 4 Objects and effects of acquisition Not Applicable. (including but not limited to, disclosure of reasons for acquisition of target entity, if its business is outside the main line of business of the listed entity) 5 Brief details of any governmental or Not Applicable. regulatory approvals required for the acquisition. Corporate Office: Level 8, Prestige Palladium Bayan, No. 129-140 Greams Road, Chennai, Tamil Nadu, 600006 FISCHER MEDICAL VENTURES LIMITED (Formerly [Showing first 8,000 characters — download PDF for full document]